
BriaCell Therapeutics Corp.
BCTXHealthcare|Biotechnology|CA
$3.95
+0.68 (+20.80%)
DCF Value
$0.59
Tangible Book / Share
$1.77
Cash / Share
$2.36
Ownership Breakdown
90.4%
Float
8.7M
Shares Outstanding
7.9M
Float Shares
Major Holders (10)
Combined: 71.3%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Marc Lustig | Individual | 10.70% | 4,031,370 | Dec 12, 2024 | 13D/G |
| Kenneth Griffin | HC, IN | 9.99% | 717,198 | Jan 23, 2026 | 13D/G |
| Citadel Advisors LLC | IA, HC, OO | 9.98% | 716,699 | Jan 23, 2026 | 13D/G |
| Citadel Advisors Holdings LP | HC, PN | 9.98% | 716,699 | Jan 23, 2026 | 13D/G |
| Citadel GP LLC | HC, OO | 9.98% | 716,699 | Jan 23, 2026 | 13D/G |
| Richard Abbe | HC, IN | 4.99% | 98,944 | Nov 14, 2025 | 13D/G |
| CVI Investments, Inc. | Corporation | 4.90% | 98,944 | Nov 7, 2025 | 13D/G |
| Heights Capital Management, Inc. | Corporation | 4.90% | 98,944 | Nov 7, 2025 | 13D/G |
| Kimberly Page | Individual | 2.95% | 57,200 | Nov 14, 2025 | 13D/G |
| Iroquois Capital Management, LLC | Other | 2.95% | 57,200 | Nov 14, 2025 | 13D/G |
Insider Trades (32)
Last 4 quarters: 52,530 acquired · 654,572 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lustig Marc | director, 10 percent owner: | May 14, 2024 | BUY | 902,935 | $2.21 | $2.0M | Form 4 |
| Lustig Marc | director, 10 percent owner: | May 14, 2024 | BUY | 902,935 | $2.11 | $1.9M | Form 4 |
| Bondarenko Jamieson | Chairman | Dec 28, 2022 | BUY | 28,000 | $4.58 | $128.2K | Form 4 |
| Williams William V. | President, CEO | Dec 23, 2022 | BUY | 2,530 | $1.94 | $4.9K | Form 4 |
| Bondarenko Jamieson | director | Dec 20, 2022 | BUY | 22,000 | $5.35 | $117.7K | Form 4 |
| Bondarenko Jamieson | director | Aug 1, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Bondarenko Jamieson | director | Mar 29, 2021 | DISPOSED | 150,000 | $4.24 | $636.0K | Form 4 |
| Bondarenko Jamieson | director | Aug 1, 2022 | DISPOSED | 250,000 | $8.47 | $2.1M | Form 4 |
| Bondarenko Jamieson | director | Aug 12, 2021 | DISPOSED | 70,000 | $5.31 | $371.7K | Form 4 |
| Lustig Marc | director | Aug 1, 2022 | OTHER | 0 | — | — | Form 4 |
| Lustig Marc | director | Feb 7, 2022 | OTHER | 20,000 | $5.31 | $106.2K | Form 4 |
| Lustig Marc | director | Aug 1, 2022 | OTHER | 0 | — | — | Form 4 |
| Lustig Marc | director | Feb 7, 2022 | OTHER | 20,000 | $5.31 | $106.2K | Form 4 |
| Del Priore Giuseppe | Chief Medical Officer | Aug 1, 2022 | DISPOSED | 150,000 | $7.51 | $1.1M | Form 4 |
| Taub Rebecca | director | Aug 1, 2022 | DISPOSED | 10,000 | $8.47 | $84.7K | Form 4 |
| Taub Rebecca | director | Mar 29, 2021 | DISPOSED | 10,000 | $4.24 | $42.4K | Form 4 |
| Lopez-Lago Miguel A. | Chief Scientific Officer | Aug 1, 2022 | DISPOSED | 15,000 | $8.47 | $127.1K | Form 4 |
| Schmieg Martin E. | director | Aug 1, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Schmieg Martin E. | director | Aug 1, 2022 | DISPOSED | 50,000 | $8.47 | $423.5K | Form 4 |
| Schmieg Martin E. | director | Mar 29, 2021 | DISPOSED | 25,000 | $4.24 | $106.0K | Form 4 |
| Embro-Pantalony Vaughn C. | director | Aug 1, 2022 | OTHER | 0 | — | — | Form 4 |
| Embro-Pantalony Vaughn C. | director | Aug 1, 2022 | DISPOSED | 50,000 | $8.47 | $423.5K | Form 4 |
| Embro-Pantalony Vaughn C. | director | Mar 29, 2021 | DISPOSED | 25,000 | $4.24 | $106.0K | Form 4 |
| Williams Williams V. | director, officer: President & CEO | Aug 1, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Williams Williams V. | director, officer: President & CEO | Jul 14, 2022 | DISPOSED | 27,272 | $5.31 | $144.8K | Form 4 |
| Williams Williams V. | director, officer: President & CEO | Aug 1, 2022 | DISPOSED | 22,300 | $8.47 | $188.9K | Form 4 |
| Williams Williams V. | director, officer: President & CEO | Mar 29, 2021 | DISPOSED | 200,000 | $4.24 | $848.0K | Form 4 |
| Gross Jane A | director | Nov 1, 2021 | DISPOSED | 10,000 | $7.74 | $77.4K | Form 4 |
| Gross Jane A | director | Aug 1, 2022 | DISPOSED | 50,000 | $8.47 | $423.5K | Form 4 |
| LEVIN GADI | CFO & Secretary | Aug 1, 2022 | DISPOSED | 0 | — | — | Form 4 |
| LEVIN GADI | CFO & Secretary | Aug 1, 2022 | DISPOSED | 20,000 | $4.71 | $94.2K | Form 4 |
| LEVIN GADI | CFO & Secretary | Mar 29, 2021 | DISPOSED | 75,000 | $4.24 | $318.0K | Form 4 |